Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 5;11(7):654.
doi: 10.3390/life11070654.

Genetic Investigation of Inverse Psoriasis

Affiliations

Genetic Investigation of Inverse Psoriasis

Anikó Göblös et al. Life (Basel). .

Abstract

Inverse psoriasis is considered to be a rare variant of plaque-type psoriasis and is associated with significantly impaired quality of life. Clinical manifestations and treatment options are somewhat different for each subtype. Identifying genetic variants that contribute to the susceptibility of different types of psoriasis might improve understanding of the etiology of the disease. Since we have no current knowledge about the genetic background of inverse psoriasis, whole exome sequencing was used to comprehensively assess genetic variations in five patients with exclusively inverse lesions. We detected six potentially pathogenic rare (MAF < 0.01) sequence variants that occurred in all investigated patients. The corresponding mutated genes were FN1, FBLN1, MYH7B, MST1R, RHOD, and SCN10A. Several mutations identified in this study are known to cause disease, but roles in psoriasis or other papulosquamous diseases have not previously been reported. Interestingly, potentially causative variants of established psoriasis-susceptibility genes were not identified. These outcomes are in agreement with our hypothesis that the inverse subtype is a different entity from plaque-type psoriasis.

Keywords: WES; genetic background; inverse psoriasis; pathogenic gene variants; whole exome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study, the collection, analyses, or interpretation of data, the writing of the manuscript, or the decision to publish the results.

Figures

Figure 1
Figure 1
Clinical manifestation of inverse psoriasis.
Figure 2
Figure 2
Confidence-based protein-interaction network for variant genes identified in inverse psoriasis.

References

    1. Dattola A., Silvestri M., Bennardo L., Del Duca E., Longo C., Bianchi L., Nisticò S. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review. Dermatol. Ther. 2018;31:e12728. doi: 10.1111/dth.12728. - DOI - PubMed
    1. Kaskas N., Merola J.F., Qureshi A.A., Paek S.Y. Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting. J. Rheumatol. 2017;44:695–696. doi: 10.3899/jrheum.170149. - DOI - PubMed
    1. Meeuwis K.A.P., Bleakman A.P., Van De Kerkhof P.C.M., Dutronc Y., Henneges C., Kornberg L.J., Menter A. Prevalence of genital psoriasis in patients with psoriasis. J. Dermatol. Treat. 2018;29:754–760. doi: 10.1080/09546634.2018.1453125. - DOI - PubMed
    1. Wang G., Li C., Gao T., Liu Y. Clinical analysis of 48 cases of inverse psoriasis: A hospital-based study. Eur. J. Dermatol. 2005;15:176–178. - PubMed
    1. Meeuwis K., Hullu J., Massuger L., Kerkhof P., Rossum M. Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease. Acta Derm. Venereol. 2011;91:5–11. doi: 10.2340/00015555-0988. - DOI - PubMed

LinkOut - more resources